Clinical significance of detecting serum CysC,Cyfra21-1 and NSE levels before and after operation in patients with lung cancer
10.3969/j.issn.1673-4130.2014.23.017
- VernacularTitle:肺癌患者手术治疗前、后血清CysC、CYfra21-1和NSE水平检测的临床意义
- Author:
Jinfeng CAO
;
Jianming ZHOU
- Publication Type:Journal Article
- Keywords:
lung cancer;
cystatin C;
cytokeratin fragment antigen 21-1;
neuro-specific enolase
- From:
International Journal of Laboratory Medicine
2014;(23):3194-3195
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare the changes of serum cystatin C(CysC),cytokeratin 19 fragment(CYfra21-1)and neuro-spe-cific enolase(NSE)levels before and after surgery in the patients with lung cancer.Methods ELISA and the chemiluminescence method were adopted to detect the levels of serum CysC,CYfra21-1 and NSE before and after operation in 33 patients with lung cancer and the detection results were compared with those in 35 health people.Results The serum CysC,CYfra21-1 and NSE levels in the lung cancer patients were significantly higher than those in the normal control group(P <0.01);which had statistically sig-nificant difference between before and after operation(P <0.05);the serum CysC,CYfra21-1 and NSE levels in 3 months after op-eration still had statistically significant difference compared with the normal people(P <0.05),moreover the serum CysC level was positively correlated with serum CYfra21-1and NSE levels(r =0.601 8,0.596 6,P <0.01 ).Conclusion Detecting serum cyscC, CYfra21-1 and NSE level change has certain clinical value for evaluating the prognosis and the disease condition monitoring of the patients with lung cancer.
